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Abstract
Background: Low cardiorespiratory fitness and inactivity are 
common after lung transplantation (LTx). The causes of ex-
ercise intolerance are incompletely understood. Objectives: 
The aim of this study was to objectively assess cardiorespira-
tory fitness and physical activity, evaluate causes of exercise 
intolerance, and explore clinical factors associated with car-
diorespiratory fitness after bilateral LTx (BLTx). Materials 
and Methods: Peak oxygen uptake (V
∙
O2peak) and exercise-
limiting factors were evaluated by a treadmill cardiopulmo-
nary exercise test (CPET) 6–60 months after BLTx. Physical 
activity was measured with accelerometers, and results were 
compared with Norwegian normative data and the World 
Health Organization’s (WHO) recommendations for physical 
activity. Results: In 54 included BLTx recipients (mean age 50 
± 15 years, 50% females), V
∙
O2peak (mL × kg–1 × min–1) was 
21.8 ± 7.7 for men and 22.4 ± 6.2 for women, corresponding 
to 57 ± 17 and 70 ± 12% of predicted, respectively. Three pa-





O2peak in 22 patients (41%), while ventilatory limita-
tion and abnormal gas exchange were observed in 14 (26%) 
and 20 (37%) patients, respectively (some had more than 1 
finding). Forty-three patients (86%) did not meet the WHO 
physical activity recommendations. There was a moderate 
correlation between V
∙
O2peak and physical activity (r = 0.642, 
p < 0.01). Body mass index, physical activity, forced expira-
tory volume after 1 second, sex, and hemoglobin together 
accounted for 73% of the variability in V
∙
O2peak. Conclusions: 
Low cardiorespiratory fitness was observed in the majority 
of BLTx recipients. Both deconditioning and cardiopulmo-
nary limitations were common findings. Nearly 90% were 
classified as being inactive according to physical activity rec-
ommendations. CPET appears to identify a deconditioned 
subgroup of BLTx recipients for whom exercise training may 
be especially beneficial. © 2020 The Author(s)
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Lung transplantation (LTx) is a well-established life-
saving treatment for patients with end-stage lung disease, 
with nearly 5,000 transplants performed each year world-
wide [1]. Exercise intolerance often persists for several 
years following LTx, despite success of the surgical pro-
cedure and improved lung function [2]. The causes of ex-
ercise intolerance in this population are incompletely un-
derstood.
In the general population, cardiorespiratory fitness is 
reported to be a stronger predictor of mortality than well-
acknowledged risk factors, such as hypertension, smok-
ing, obesity, hyperlipidemia, and diabetes [3, 4], and is 
also associated with cardiovascular morbidity and health-
related quality of life (HRQoL) [5]. As many as 30–50% of 
LTx recipients develop comorbid conditions, such as dia-
betes and hyperlipidemia, in the years after transplanta-
tion, and the majority are diagnosed with hypertension by 
5 years after transplant [1]. Thus, cardiorespiratory fitness 
in this vulnerable LTx population is potentially an impor-
tant factor related to overall health and delaying lifestyle 
diseases and mortality. While a number of studies have 
measured cardiorespiratory fitness in LTx recipients, the 
majority were performed in an earlier era of LTx (in the 
1990s) [6–10] or are limited by small sample sizes (n < 25) 
[6–12]. While physical activity is known to be reduced 
among LTx recipients both before and after transplant [2], 
the relationship between physical activity and cardiore-
spiratory fitness in this population is not well established. 
Finally, it is unclear which demographic and clinical fac-
tors influence cardiorespiratory fitness after LTx. 
In this cross-sectional study, we aimed to determine 
cardiorespiratory fitness and level of physical activity in a 
nationwide cohort of bilateral LTx (BLTx) recipients. 
Further, we aimed to identify causes of exercise intoler-
ance, study the relationship between cardiorespiratory 
fitness and physical activity, and explore clinical factors 






In this national cohort study, BLTx recipients were recruited at 
Oslo University Hospital between August 2017 and June 2018. In 
Norway, all organ transplantations are performed in 1 center, 
which serves the entire Norwegian population of approximately 
5.3 million. Since 2012, only BLTx, and no single LTx, has been 
performed. 
Eligible patients were ≥18 years of age with stable condition 6 
months to 5 years after BLTx. The patients were classified as “sta-
ble” if their pulmonary function had not changed precipitously 
(defined as a reduction in forced expiratory volume after 1 second 
[FEV1] > 10%) over the past 6 months and if they did not have any 
other acute and/or function-limiting conditions under ongoing 
treatment in the opinion of the treating pulmonologist. Patients 
were not eligible if they could not communicate in Norwegian or 
were unable to walk on a treadmill until exhaustion due to muscu-
loskeletal conditions. All patients received triple-drug immuno-
suppression (tacrolimus or cyclosporine, mycophenolate mofetil, 
and corticosteroids) except 1 who did not take mycophenolate 
mofetil due to leukopenia. All BLTx recipients at our institution 
start postoperative physical therapy as soon as medically advisable. 
During the hospital stay – usually lasting 4–6 weeks – they have 
daily sessions with a physical therapist. After discharge, the pa-
tients are referred to local physical therapists. Most patients attend 
sessions 1–2 times per week for up to 6 months. Patients who need 
more intensive training are referred to a 4-week inpatient program 
at a national facility for cardiopulmonary rehabilitation. After 6 
months, the patients are encouraged to maintain regular physical 
activity at their own discretion. Written informed consent was ob-
tained from all patients prior to enrollment. Ethical approval was 
obtained from the Regional Committee for Medical and Health 
Research Ethics (REK South-East, No. 2017/399).
Clinical Characteristics
Data on native lung disease, time since BLTx, comorbidities, 
and medications were obtained from the patients’ medical records. 
Registered comorbidities included anemia, renal dysfunction, ar-
terial hypertension, diabetes, and overweight. Anemia was defined 
as a hemoglobin concentration (Hb) < 13 g × dL–1 for men and 
< 12 g × dL–1 for women. Moderate anemia was defined as Hb < 11 
and < 10 g × dL–1 and severe anemia as Hb < 8 and < 7 g × dL–1 for 
men and women, respectively [13]. Renal dysfunction was defined 
as an estimated glomerular filtration rate < 60 mL × min–1 × 1.73 
m–2 in accordance with local reference values. Hypertension was 
defined as the use of antihypertensive drugs, and diabetes was de-
fined as the use of antidiabetic drugs. Overweight was defined as a 
body mass index (BMI) ≥25 kg × m–2, and obesity was defined as 
a BMI ≥30 kg × m–2, in line with the World Health Organization 
(WHO) classification [14]. Chronic lung allograft dysfunction 
(CLAD) was defined as a persistent decline in FEV1 of 20% from 
the mean of the 2 highest posttransplant values in the absence of 
other explanatory conditions [15].
Pulmonary Function Tests
Pulmonary function was assessed by spirometry and diffusing 
capacity of the lungs for carbon monoxide (DLCO; Jaeger Master 
Screen Body, Eric Jaeger, Wurzburg, Germany) in accordance with 
the recommendations of the ATS/ERS task force [16, 17]. Refer-
ence values were calculated using the Global Lung Function Initia-
tive equations [18, 19]. 
Cardiopulmonary Exercise Test
Under guidance of an exercise physiologist and a physician, all 
patients performed a maximal symptom-limited cardiopulmonary 
exercise test (CPET) on a treadmill (TechnoGym Runrace, Forli, 
Italy) using a modified Balke protocol [20] that was also used for 





3.8, or 4.8 km × h–1, depending on the patient’s self-reported level 
of fitness and performance during familiarization with the tread-
mill prior to CPET. The inclination was set to 4% and increased by 
2% every minute. If the patient reached the maximum inclination 
of 20%, the speed was increased by 0.5 km × h–1 every minute un-
til exhaustion. Gas exchange and exhaled volumes were directly 
measured breath-by-breath (Vyntus CPX Metabolic Cart, CareFu-
sion Corporation, Höchberg, Germany). Prior to each test, the 
metabolic cart was calibrated for volume and gas according to the 
standards given by the manufacturer. The highest V
․
O2 measured 
over 30 s was defined as V
․
O2peak. Percutaneous oxygen saturation 
(SpO2) was measured with finger pulse oximeter (NONIN8600, 
Medical Inc., Minneapolis, MN, USA), and a 12-lead ECG (Custo 
cardio 100, CustoMed, Ottobrunn, Germany) was conducted for 
evaluation of ischemia and/or arrhythmias. After test termina-
tion, the rating of perceived exertion was assessed by the Borg 
scale6–20. Postexercise blood lactate concentration was measured 
within 60 s of stopping to objectively assess the patient’s effort 
[22]. 
Ventilatory threshold was determined by the ventilatory equiv-
alent method [23]. Minute ventilation (VE) and carbon dioxide 
output (VCO2) during CPET below the respiratory compensation 
point were used to calculate the VE/VCO2 slope. Predicted V
․
O2peak 
and peak heart rate (HRpeak) were calculated based on equations 
from Edvardsen et al. [21].
The definition of maximal effort was a high respiratory ex-
change ratio (1.0–1.10) and lactate concentration (≥3.5–9 mmol × 
L–1) relative to age and gender in accordance with the recommen-
dations by Edvardsen et al. [22]. Low cardiorespiratory fitness was 
defined as V
․
O2peak < 85% of predicted, ventilatory limitation as 
breathing reserve < 15% or < 11 L × min–1, exercise-induced hypox-
emia as SpO2 < 88%, and signs of ventilation perfusion (VQ) mis-
match (gas exchange limitation) were defined as a VE/VCO2 slope 
≥34 [24]. Poor chronotropic response was defined as a HR < 80% 
of predicted in the absence of pulmonary limitations [25]. Decon-
ditioning was defined as low cardiorespiratory fitness in the ab-
sence of cardiopulmonary limitations.
Accelerometer
For objective assessment of physical activity, all patients were 
asked to carry an accelerometer (ActiGraph GT1M, LLC, Pensac-
ola, FL, USA) for 7 consecutive days during waking hours, except 
during water-based activities. The accelerometer registered verti-
cal accelerations in counts per minute and number of steps per day. 
Moderate-to-vigorous physical activity was defined as all activity 
≥2,020 counts per minute (equivalent to 3 metabolic equivalents 
of task) occurring in bouts lasting for at least 10 min [26, 27]. Ad-
herence to physical activity recommendations was defined as ac-
cumulating a daily average of moderate-to-vigorous physical ac-
tivity accrued in bouts > 21.4 min/day in accordance with WHO 
Table 1. Characteristics of the study population
Male (n = 27) Female (n = 27) All (n = 54)
Age, years 53.3±0.6 50.0±14.5 51.6±12.7
BMI, kg×m–2 26.9±4.3 25.4±3.8 26.1±4.1
Hemoglobin, g×dL–1 13.0±1.5 11.8±1.2 12.4±1.5
Time after BLTx, months 30±16 27±16 28±16
History of smoking 11 (41) 17 (63) 28 (52)
CLAD 6 (22) 1 (4) 7 (13)
Use of β-blockers 5 (19) 6 (22) 11 (20)
Comorbidities
Anemia 14 (52) 13 (48) 27 (50)
Arterial hypertension 13 (48) 9 (33) 22 (41)
Diabetes 1 (4) 1 (4) 2 (4)
Renal dysfunction 12 (44) 14 (52) 26 (48)
Native lung disease
COPD 11 (41) 13 (48) 24 (44)
Interstitial lung disease 10 (37) 5 (19) 15 (28)
Cystic fibrosis 0 2 (7) 2 (4)
Other 6 (22) 7 (26) 13 (24)
Pulmonary function
FVC, L (% of predicted) 3.8±1.0 (79±18) 3.4±0.7 (99±19) 3.6±0.9 (89±21)
FEV1, L×s–1 (% of predicted) 2.5±0.8 (67±21) 2.6±0.7 (95±22) 2.6±0.7 (81±25)
MVV, L×min–1 (% of predicted) 112.1±34.5 (85±26) 100.2±18.6 (101±18) 106.2±28.1 (93±24)
DLCO, mmol×kPa–1×min–1 
(% of predicted) 6.7±1.6 (70±14) 5.9±1.2 (83±18) 6.33±1.5 (77±17)
Values are means ± standard deviations or n (%). BLTx, bilateral lung transplantation; BMI, body mass index; 
CLAD, chronic lung allograft dysfunction; COPD, chronic obstructive pulmonary disease; DLCO, diffusing ca-
pacity for carbon monoxide; FEV1, forced expiratory volume after 1 second; FVC, forced vital capacity; Hb, he-
moglobin concentration; MVV, maximum voluntary ventilation.




recommendations [28]. Data was included if the patients had ac-
cumulated at least 10 h of activity recordings per day for a mini-
mum of 2 days. The objectively measured physical activity was 
compared to normative values [26].
Health-Related Quality of Life
The 36-Item Short Form Health Survey (SF-36) was used to eval-
uate HRQoL. The SF-36 consists of 8 scales, which can be aggregated 
into 2 summary measures: the Physical and Mental Component Sum-
mary scores. The summary scores (scaled from 0 to 100) are based on 
data for the US general population standardized to a mean of 50 and 
SD of 10, where higher scores indicate better functioning [29]. 
Statistics 
Descriptive data are presented as means ± standard deviations 
or medians (ranges) as appropriate. Means for physical activity 
were compared to Norwegian standard values using a one-sample 
t test, assuming the difference between BLTx recipients and the 
Norwegian standard would be equal to zero. A p value of < 0.05 was 
regarded as statistically significant. Pearson correlation coeffi-
cients were calculated between V
․
O2peak, physical activity level 
(counts per minute), time since transplantation, and SF-36 scores. 
A negligible correlation was defined as < 0.30, a low correlation as 
0.30–0.49, a moderate correlation as 0.50–0.69, a high correlation 
as 0.70–0.89, and a very high correlation as ≥0.90 [30].
To explore potential factors associated with cardiorespiratory 
fitness, univariate regression analyses were used, where V
․
O2peak in 
% of predicted was set as the dependent variable. To identify the 
degree of association with V
․
O2peak, the relevant variables with sig-
nificant associations in univariate analyses (p < 0.05) and other 
clinical variables known to affect V
․
O2peak (age, sex, BMI, and Hb) 
were selected for multiple regression analyses. The final model was 
built using a series of multiple regression analyses with the enter 
method. All analyses were performed using SPSS version 25.0 
(IBM Statistics, Chicago, IL, USA). 
Results
Of 73 patients assessed for eligibility, 16 declined 
participation and 3 could not be tested due to unstable 
health conditions. In total, 27 men and 27 women 
(mean age 50 ± 15, range 20–67 years) were included in 
the study 6–59 months after BLTx. Clinical character-
istics and pulmonary function are presented in Table 1. 
Twenty-two patients (41%) had mild anemia and 5 pa-
tients (9%) had moderate anemia. Twenty-seven pa-
tients (50%) were overweight (BMI 25–29) and 9 (17%) 
were obese (BMI > 30). Seven patients, of whom 6 were 
men, had been diagnosed with CLAD prior to study en-
rollment (Table 1).
Cardiorespiratory Fitness
No adverse events were recorded during or after the 
CPET. Table 2 shows cardiopulmonary response during 
CPET. All but 2 patients reported exertion ≥17 on the 
Borg scale at peak exercise. Fourteen patients did not 
reach the recommended age- and gender-adjusted end-
criteria for lactate concentration and respiratory ex-
change ratio. Leg fatigue was the most frequent reason for 
stopping the CPET (46%) followed by dyspnea (31%) and 
general exhaustion (22%). 
Three patients (6%) had normal cardiorespiratory fit-
ness. Among the 51 patients (95%) with low cardiorespi-
ratory fitness, 14 patients (26%) were ventilatory limited, 
1 patient (2%) had exercise-induced hypoxemia, and 20 
Table 2. Cardiopulmonary response during cardiopulmonary exercise testing in bilateral lung transplant recipi-
ents
Men (n = 27) Women (n = 27) All (n = 54)
V
․
O2peak, mL×kg–1×min–1 (% of predicted) 21.8±7.7 (57±17) 22.4±6.2 (70±12) 22.1±6.9 (64±16)
V
․
O2peak, L×min–1 (% of predicted) 1.78±0.49 (55±13) 1.51±0.24 (69±11) 1.65±0.41 (62±14)
VT, L×min–1 (% of predicted) 1.41±0.39 (62±15) 1.18±0.20 (72±12) 1.28±0.32 (67±14)
Peak ventilation, L×min–1 (% of predicted) 78.6±22.8 (68±18) 67.48±15.4 (85±17) 73.0±20.1 (77±20)
Respiratory rate, breaths×min–1 38.6±6.9 36.4±8.8 37.5±7.9
Breathing reserve, % 27.9±14.2 31.9±12.7 29.9±13.5
VE/VCO2 slope 35.6±10.5 33.0±4.5 34.3±8.1
HRpeak, beats×min–1 (% of predicted) 145.3±17.1 (84±9) 155.7±19.2 (89±9) 150.5±18.8 (86±9)
O2-pulse, mL×beat–1 (% of predicted) 12.2±2.7 (67±14) 9.8±1.5 (80±14) 11.0±2.5 (73±15)
Lowest SpO2 during test, % 94 (87–98) 96 (90–99) 95 (87–99)
Borg scale6–20 18.1±1.13 18.3±0.9 18.2±1.0
Blood lactate, mmol×L–1 7.8±2.7 8.7±2.1 8.3±2.4
Respiratory exchange ratio, VCO2/VO2 1.08±0.13 1.15±0.07 1.12±0.11
Data are presented as means ± standard deviations or medians (ranges). HRpeak, peak heart rate; V
․
O2peak, 





patients (37%) had an elevated VE/VCO2 slope indicating 
V/Q mismatch. No patient showed signs of myocardial 
ischemia during CPET. However, 4 patients had poor 
chronotropic response (3 used β-blockers and 1 had per-
manent atrial fibrillation). Some patients had more than 
1 cardiopulmonary factor limiting exercise and have been 
counted more than once. Twenty-two patients (41%) 
were classified as deconditioned without cardiopulmo-
nary limiting factors of whom 13 (59%) had mild anemia. 
Nine of the patients with ventilatory limitations had 
known respiratory pathology (CLAD, n = 6; sequela of 
pulmonary infection, n = 1; dynamic airway collapse, n = 
1; airway stenosis, n = 1). 
Physical Activity 
Fifty recipients (93%) accumulated at least 10 h of val-
id activity recordings per day for at least 2 days. The mean 
accelerometer wear time was 15 ± 2 h per day for 5.9 ± 1.9 
days. Compared to the Norwegian national standard, 
BLTx recipients walked significantly fewer steps per day 
(5,451 ± 3,398 vs. 8,241, p < 0.001), had significantly few-
er counts per minute (226 ± 131 vs. 366, p < 0.001; Fig. 1), 
and had 30% higher sedentary time (p < 0.001). Forty-
three patients (86%) were classified as physically inactive 
[28]. The 7 patients (14%) meeting the WHO’s physical 
activity recommendations had significantly higher 
V
․
O2peak than those who did not (79 ± 7 vs. 62 ± 15% of 






























Fig. 1. Objectively measured physical activ-
ity expressed as counts per minute (a) and 
steps per day (b) (mean ± SD) in 54 bilat-
eral lung transplant recipients. The dotted 
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Fig. 2. a Correlation between V
․
O2peak (mL 
× kg–1 × min–1) and physical activity 
(counts per minute). b Correlation be-
tween peak oxygen uptake (V
․
O2peak) in per-
cent of predicted and months since bilat-
eral lung transplantation (BLTx). c, d Cor-
relations between peak oxygen uptake 
(V
․
O2peak) in percent of predicted and SF-36 
physical component summary score (SF-
36 PCS; c) and SF-36 mental component 
summary score (SF-36 MCS; d). Higher 
SF-36 score indicates better health-related 
quality of life.




Associations with Cardiopulmonary Fitness
Correlations between V
․
O2peak and physical activity 
level, time since transplantation, and HRQoL are present-
ed in Figure 2. There was a moderate correlation between 
V
․
O2peak and physical activity level (measured by counts 
per minute) and between V
․
O2peak and the physical aspect 
of HRQoL (measured by the SF-36 physical component 
summary score). There was a negligible correlation be-
tween V
․
O2peak and time since transplantation, and be-
tween V
․
O2peak and the mental aspect of HRQoL (mea-
sured by the SF-36 mental component summary score). 
Univariate and multivariable analyses for associations 
with V
․
O2peak are presented in Table 3. Univariate regres-
sion analysis indicated that sex, age, BMI, physical activ-
ity, the physical aspect of HRQoL, FEV1, and DLCO were 
significantly associated with V
․
O2peak. The final multivari-
able regression model showed that BMI, physical activity, 





We found that only 3 out of 54 BLTx recipients had 
normal cardiorespiratory fitness (V
․
O2peak) and that phys-
ical activity level was low. CPET results revealed that both 
deconditioning and cardiopulmonary factors caused ex-
ercise intolerance. Forty-three patients (86%) did not 
meet the WHO’s physical activity recommendations, and 
daily sedentary time was 30% greater than in a healthy 
Norwegian population. We further demonstrated that 
V
․
O2peak is associated with physical activity level after BLTx.
Our results showed that V
․
O2peak is low among BLTx 
recipients and that considerable exercise intolerance per-
sists after BLTx. This is in line with findings from previ-
ous studies showing minimal increase in V
․
O2peak after 
BLTx and does not match the large improvement in pul-
monary function [31, 32]. However, in our population, 
low cardiorespiratory fitness was caused by both decon-
ditioning and cardiopulmonary limitations. The high 
number (n = 29) of patients with cardiopulmonary limi-
tations to exercise was somewhat surprising, as chronic 
muscle deconditioning and skeletal muscle abnormalities 
have been proposed as the main exercise-limiting factors 
in previous studies [32]. 
Table 3. Univariate and multiple regression analysis using V
․
O2peak % of predicted as dependent variable in BLTx 
recipients (n = 54)
Univariate regression analysis Multivariable regression 
model (R2 = 0.726)
unstandarized β 
(95% CI)
R2 p value unstandarized β 
(95% CI)
Gender, female 12.8 (4.9 to 20.7) 0.17 0.002 8.8 (2.6 to 14.9)
Age, years –0.3 (–0.7 to –0.01) 0.08 0.044 0.1 (–0.2 to 0.3)
BMI, kg×m–2 –2.2 (–3.1 to –1,3) 0.35 <0.001 –2.0 (–2.9 to –1.2)
Physical activity, counts per min 0.08 (0.04 to 0.1) 0.33 <0.001 0.05 (0.03 to 0.07)
Time since BLTx, years –0.2 (–3.4 to 3.0) <0.001 0.991
SF-36 PCS 0.9 (0.5 to 1.4) 0.27 <0.001
SF-36 MCS 0.1 (–0.4 to 0.6) 0.002 0.788
FEV1, % of predicted 0.3 (0.1 to 0.4) 0.20 0.001 0.2 (0.1 to 0.3)
DLCO, % of predicted 0.4 (0.2 to 0.6) 0.21 0.001
Hb, g×dL–1 0.1 (–2.8 to 3.0) <0.001 0.923 2.8 (0.9 to 4.7)
Emphysema prior to BLTx –0.2 (–8.9 to 8.5) <0.001 0.960
Renal insufficiency –3.8 (–12.4 to 4.7) 0.02 0.371
Arterial hypertension –6.1 (–14.7 to 2.6) 0.04 0.165
Use of β-blockers –8.9 (–19.4 to 1.5) 0.05 0.093
BLTx, bilateral lung transplantation; BMI, body mass index; FEV1, forced expiratory volume after 1 second; 
DLCO, diffusing capacity; Hb, hemoglobin concentration; SF-36 MCS, 36-Item Short Form Health Survey Men-





Patients who were deconditioned had low oxygen 
pulse, indicating poor stroke volume, but normal gas ex-
change and adequate breathing reserve. A similar combi-
nation has been observed in deconditioned individuals in 
other clinical settings [24]. For such patients, exercise 
therapy may be especially beneficial.
A low breathing reserve raises the possibility of venti-
latory limitation to exercise [23]. One-fourth of the pa-
tients were ventilatory limited. As expected, patients with 
ventilatory limitations also had low HRpeak and did not 
reach the end-criteria for maximal effort (high respira-
tory exchange ratio and blood lactate concentration). 
Ventilatory limitation to exercise could in most cases be 
explained by respiratory pathology. Some of the patients 
had experienced severe loss of pulmonary function 
(FEV1) due to CLAD or other postoperative complica-
tions. Ventilatory limitation has not been reported in ear-
lier studies [8, 31, 33], possibly due to missing data on 
patients with postoperative lung complications, early 
CPET termination, or the use of a different exercise mode. 
The exercise mode may have played an important role in 
detecting ventilatory limitations in the present study. Our 
patients were tested by uphill walking on a treadmill, 
which is a more functional way of moving than cycle er-
gometer and is known to elicit 10–20% higher V
․
O2peak 
because larger muscle groups are involved [24]. Tread-
mill testing therefore places a higher demand on the car-
diopulmonary system. The higher HRpeak reported in our 
study compared to that in previous BLTx studies also sup-
ports this possibility [6, 7, 33]. 
An elevated VE/VCO2 slope, demonstrating excessive 
ventilation relative to metabolic demand, is normally 
caused by increased dead space ventilation (ventilation-
perfusion mismatch) [34]. An elevated VE/VCO2 slope 
was seen in many of our patients. This finding was ob-
served in patients with and without known postoperative 
lung complications and independent of elapsed time 
since transplantation. Our findings are in line with those 
reported by Schwaiblmair et al. [33], who described ven-
tilation-perfusion mismatch in patients 3 months after 
BLTx. However, in contrast to a study by Habedank et al. 
[12] suggesting that ventilatory inefficiency improves 
rapidly after BLTx and meets normal values within 24 
months, we observed that ventilatory inefficiency persists 
up to 5 years after BLTx. 
Previous studies have shown reduced levels of physical 
activity after LTx [2, 35, 36]. Our study confirms this find-
ing and further demonstrates that V
․
O2peak is moderately 
associated with physical activity after BLTx. In order to 
improve V
․
O2peak and reduce the risk of certain noncom-
municable diseases (cardiovascular disease, diabetes, os-
teoporosis, various cancers, and depression), the WHO 
recommends at least 150 min of moderate-to-vigorous 
physical activity, performed in bouts lasting at least 10 
min per week [28]. The vast majority of BLTx recipients 
in our study did not meet this criterion. Importantly, we 
found that higher V
․
O2peak was associated with higher 
physical activity level, and patients meeting the WHO 
recommendations for physical activity had a significantly 
higher V
․
O2peak than those who did not. In future studies, 
reporting comparison between national standards and 
the WHO recommendations may be useful since it will 
enable comparisons across different centers. 
With respect to possible predictors of V
․
O2peak, we ob-
served a high prevalence of anemia, which is known to 
affect V
․
O2peak negatively [23, 37]. Anemia alone is un-
likely to fully explain the low V
․
O2peak, given that the ma-
jority only had mild anemia but still had substantial im-
pairment in V
․
O2peak [37]; however, multivariable analysis 
suggests that it may be an important contributor. The 
causes of anemia in our study population are likely mul-
tiple and may include adverse effects of immunosuppres-
sive medications; nonetheless, it is reasonable to specu-
late that some patients may have modifiable causes of 
anemia, such as iron deficiency, for which treatment may 
help improve cardiorespiratory fitness and physical activ-
ity. 
Another contributor to lower V
․
O2peak was higher BMI. 
Weight gain after LTx is common, and median weight 
gain of 10% in the first year after LTx has been observed 
[38]. The high number of overweight or obese patients in 
our study is a matter of concern, as it may have an impact 
on V
․
O2peak and morbidity. This finding, together with the 
low levels of physical activity, highlights the need to de-
velop targeted exercise interventions after BLTx and as-
sess their effect on patient-centered outcomes in clinical 
trials. Females in the present study had significantly high-
er V
․
O2peak % of predicted than males, which is interesting 
as female recipients have shown significantly improved 
survival over 5 years compared to males [39], and higher 
V
․
O2peak is associated with improved survival in the gen-
eral population [4]. To our knowledge, no study has as-
sessed V
․
O2peak as a predictor of mortality after LTx, and 
its relevance should be investigated in future prospective 
studies. We recognize that the impact of gender on 
V
․
O2peak might be biased by the higher prevalence of 
CLAD among males in this study (6 of 7 patients with 
CLAD were males). However, exclusion of the 7 patients 
diagnosed with CLAD in the analyses did not eliminate 
the significant gender difference. 




Limitations of our study include the cross-sectional 
design, which does not permit us to define causal rela-
tionships. However, our large sample size relative to prior 
studies and the complexity of our physiological assess-
ments nonetheless allow for a thorough analysis of the 
factors associated with V
․
O2peak and physical activity in 
BLTx recipients. The causes of exercise intolerance after 
BLTx are incompletely understood, but impaired oxida-
tive function of skeletal muscle has previously been recog-
nized as a potentially important factor [10, 40]. We did not 
have the opportunity to formally assess the oxidative func-
tion of skeletal muscle, for example with muscle biopsies. 
In conclusion, low cardiorespiratory fitness was ob-
served in nearly all BLTx recipients. Deconditioning and 
cardiopulmonary factors limiting exercise were equally 
common. Only a small minority met standard recom-
mendations for physical activity. Lower physical activity 
levels were associated with lower cardiorespiratory fit-
ness. Our findings highlight the need to develop targeted 
exercise interventions after BLTx. CPET appears to iden-
tify a deconditioned subgroup of BLTx recipients for 
whom exercise training may be especially beneficial.
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